Alimera Sciences raises $40mm through the sale of Series A preferred shares
- Controlled Release
- Site Specific
- Drug Delivery
- Implantable Devices
- Private Placement
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.